GSK To Reveal More Drug Data From Clinical Trials
Last week, GlaxoSmithKline announced that it plans to make much of its drug data from clinical trials available to researchers beginning in 2013, making it the first major drugmaker to do so. Under the new policy, GSK would establish an independent panel of experts to review researchers' information requests.
- "GlaxoSmithKline To Reveal More Drug Secrets" (Hirschler, Reuters, 10/11).
- "Glaxo Opens Door to Data on Research" (Thomas, New York Times, 10/11).